Published
No data is available on the compatibility of spikes and cannulas for zolbetuximab administration
  • Astellas has compatibility data supporting physicochemical compatibility with the diluent and medical apparatus materials during zolbetuximab reconstitution and withdrawal.1
  • Astellas recommends reconstituting zolbetuximab as per the prescribing information and administering zolbetuximab infusions according to hospital protocols for intravenous medications and local prescribing information.1

  1. Data on File.

If you are not able to find the information through the Search function, please contact our Medical Communications and Engagement Department by using any of the channels below:

Connect with Field Medical

Connect with Field Medical

Medical Science Liaisons (MSLs) and Medical Value and Access (MV&A) team members are available to help answer your scientific and health economic questions.

 

Submit an Inquiry

Submit an Inquiry

For any medical inquiries, please submit your question online to Astellas Medical Information or call or fax your inquiry.

Astellas Phone: 1-800-727-7003

Fax: 1-877-829-7942

Hours: M–F, 8 AM–4:30 PM (CT)

Report an Adverse Event or Product Complaint

Report an Adverse Event or Product Complaint

Report adverse events and product complaints to Astellas or FDA MedWatch.

Astellas Phone: 1-800-727-7003

FDA MedWatch: 1-800-FDA-1088

Hours: M–F, 8 AM–4:30 PM (CT)